Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Anti-VEGF aptamer improves vision without adverse events in AMD patients

March 6, 2002

Specific ROCK inhibitor with potential as a novel glaucoma treatment

March 6, 2002

Calpain inhibitor selected for development in ocular diseases

March 6, 2002

New product for allergic conjunctivitis recommended for E.U. approval

Feb. 27, 2002

Sucampo licenses tacrolimus from Fujisawa for ophthalmic use

Feb. 21, 2002

Mutations in optineurin responsible for adult-onset primary open-angle glaucoma

Feb. 13, 2002

Chlorambucil in the treatment of sight-threatening ocular inflammation

Feb. 7, 2002

U.S. launch of Paremyd scheduled for March

Jan. 29, 2002

Naturally occurring angiostatic agents identified by Scripps to have potential in eye diseases

Jan. 28, 2002

Allergan and EntreMed enter five-year strategic alliance in eye diseases

Jan. 24, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...